Watchlist Price Alert

Deciphera Pharmaceuticals... (DCPH)

NASDAQ: DCPH · Real-Time Price · USD

25.59

0.02 (0.08%)

At close: Jun 10, 2024, 8:00 PM

Deciphera Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	83.51M	64.74M	87.06M	135.9M	120.32M	293.76M	196.75M	57.46M
Short-Term Investments	222.71M	259.75M	198.57M	416.03M	459.26M	n/a	n/a	n/a
Long-Term Investments	46.7M	14.55M	41.95M	9.38M	1.51M	1.07M	n/a	n/a
Other Long-Term Assets	8.28M	3.28M	3.11M	3.1M	n/a	n/a	75K	179K
Receivables	31.95M	22.43M	20.59M	13.9M	n/a	n/a	n/a	n/a
Inventory	21.21M	20.56M	14.13M	5.72M	n/a	n/a	n/a	n/a
Other Current Assets	21.72M	25.48M	18.66M	12.49M	13.83M	7.27M	1.43M	791K
Total Current Assets	381.1M	392.96M	339.01M	584.03M	593.41M	301.04M	198.18M	58.25M
Property-Plant & Equipment	37.49M	43.25M	45.41M	45.92M	27.49M	13.45M	838K	514K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	92.47M	61.08M	90.47M	58.4M	29M	14.52M	913K	693K
Total Assets	473.57M	454.04M	429.48M	642.43M	622.41M	315.56M	199.09M	58.95M
Account Payables	26.48M	18.61M	13.13M	12.31M	19.57M	8.31M	4.39M	1.41M
Deferred Revenue	68.35M	n/a	79.7M	n/a	n/a	194K	n/a	n/a
Short-Term Debt	3.5M	3.23M	2.87M	2.46M	1.75M	187K	187K	187K
Other Current Liabilities	1.95M	64.62M	1.07M	55.23M	38.72M	14.05M	9.23M	2.96M
Total Current Liabilities	100.28M	86.47M	96.77M	69.99M	60.04M	22.94M	13.81M	4.56M
Long-Term Debt	22.38M	25.88M	27.99M	28.76M	15.9M	12.64M	1.29M	1.48M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	194K	13K	192.67M
Total Long-Term Liabilities	22.38M	25.88M	27.99M	28.76M	15.9M	12.64M	1.31M	194.15M
Total Liabilities	122.65M	112.35M	124.76M	98.76M	75.94M	35.58M	15.12M	198.71M
Total Debt	25.88M	29.11M	30.86M	31.22M	17.65M	12.64M	1.48M	1.67M
Common Stock	805K	676K	585K	576K	516K	377K	326K	n/a
Retained Earnings	-1.43B	-1.23B	-1.05B	-754.47M	-487.98M	-295.72M	-195.87M	-145.59M
Comprehensive Income	577K	-983K	51K	11K	111K	-1.22M	-915K	-766K
Shareholders Equity	350.92M	341.69M	304.72M	543.68M	546.47M	279.98M	183.97M	-139.76M
Total Investments	269.41M	274.3M	240.52M	425.41M	460.77M	1.07M	n/a	n/a